Comparing Cenobamate vs Fycompa
| Cenobamate | Fycompa (perampanel) |
|
|---|
| Cenobamate | Fycompa (perampanel) |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Seizures. Cenobamate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Epilepsy, Seizures. Fycompa may also be used for purposes not listed in this medication guide. |
Related suggestions Seizures
|
|||||||
| More about Cenobamate | More about Fycompa (perampanel) | ||||||||
| Ratings & Reviews | |||||||||
|
Cenobamate has an average rating of 8.4 out of 10 from a total of 45 ratings on Drugs.com. 76% of reviewers reported a positive effect, while 2% reported a negative effect. |
Fycompa has an average rating of 5.8 out of 10 from a total of 66 ratings on Drugs.com. 50% of reviewers reported a positive effect, while 39% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||
|
View all Cenobamate side effects |
View all Fycompa side effects |
||||||||
| Drug Class | |||||||||
| Generic Availability | |||||||||
|
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Fycompa prices |
||||||||
| Dosage Forms | |||||||||
|
N/A |
|
||||||||
| Brand Names | |||||||||
| Xcopri |
N/A |
||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||
|
60 hours |
105 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||
|
Some potential for abuse
Has a low potential for abuse relative to those in schedule 4. Has a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to those in schedule 4. |
Moderate abuse potential
Has a potential for abuse less than those in schedules 1 and 2. Has a currently accepted medical use in treatment in the United States. Abuse may lead to moderate or low physical dependence or high psychological dependence. |
||||||||
| Pregnancy Category | |||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
||||||||
| Drug Interactions | |||||||||
|
A total of 582 drugs are known to interact with Cenobamate:
|
A total of 330 drugs are known to interact with Fycompa:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||
|
|
||||||||
| Disease Interactions | |||||||||
| First Approval Date | |||||||||
|
November 21, 2019 |
October 22, 2012 |
||||||||
| WADA Class View classifications | |||||||||
|
N/A |
N/A |
||||||||
| More Information | |||||||||
| Patient Resources | |||||||||
| Professional Resources | |||||||||
| Related Treatment Guide | |||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.